NCT06859008
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +39 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Clinical trial condition
Recurrent Grade 2 Follicular Lymphoma
Explore clinical trials studying Recurrent Grade 2 Follicular Lymphoma. Study availability and eligibility vary by location and protocol.
109 public trials
2 recruiting studies
Recurrent Grade 2 Follicular Lymphoma trial results
NCT06453044
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
Active, not recruiting
Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma
NCT01479842
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +29 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Active, not recruiting
Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
NCT02520791
- Conditions
- Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +29 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
- Yale University New Haven, Connecticut, United States
Active, not recruiting
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma
NCT01815749
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Blood Protein Disorders, Burkitt Lymphoma, +64 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, not recruiting
Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma
NCT01318317
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, not recruiting
Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma
NCT01849263
- Conditions
- Grade 3a Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- Metro Minnesota Community Oncology Research Consortium Saint Louis Park, Minnesota, United States
Active, not recruiting
Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
NCT02446457
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
NCT01199562
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, not recruiting
Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
NCT03015896
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +42 more
- Locations
-
- Emory University Atlanta, Georgia, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States